Literature DB >> 6114793

Benzodiazepine withdrawal.

Y D Lapierre.   

Abstract

As with most psychotropic sedative drugs, the potential for withdrawal reactions is present with the benzodiazepines (19). Signs suggesting the potential for withdrawal reactions can be gleaned from the clinical course of events such as the development of tolerance anc psychological and physiological dependence. If high doses are reached, the risk of withdrawal reactions increases with the length of treatment and the abruptness of cessation. The long-acting benzodiazepines have a built-in mechanism against withdrawal reactions through their active metabolites. Abrupt cessation of drug therapy in high-dose patients should be avoided to reduce the risk of withdrawal reactions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114793     DOI: 10.1177/070674378102600203

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  3 in total

1.  Treatment of triazolam dependence with a tapering withdrawal regimen.

Authors:  A N Singh; M Chemij; J Jewell
Journal:  CMAJ       Date:  1986-02-01       Impact factor: 8.262

Review 2.  Benzodiazepine dependence. A review of the evidence.

Authors:  R T Owen; P Tyrer
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

3.  Postoperative neuroleptic malignant syndrome-like symptoms improved with intravenous diazepam: a case report.

Authors:  Shun Kishimoto; Kumi Nakamura; Toshiyuki Arai; Ogino Yukimasa; Norihiko Fukami
Journal:  J Anesth       Date:  2013-04-04       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.